Cardiac Monitoring and Cardiac Rhythm Management Devices Market Size Worth USD 34.90 Billion by 2034 | CAGR: 4.85%

The cardiac monitoring and cardiac rhythm management devices market size is expected to reach USD 34.90 Billion by 2034, according to a new study by Polaris Market Research. The report “Cardiac Monitoring and Cardiac Rhythm Management Devices Market Share, Size, Trends, Industry Analysis Report: By Type, By Procedure (Invasive and Non-invasive), By Application, By End User, and By Region; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Cardiac monitoring and cardiac rhythm management (CRM) devices are critical for early diagnosis, continuous monitoring, and effective treatment of cardiovascular diseases, enabling better patient outcomes and reducing the risk of sudden cardiac events.

Questions? Request a sample or make an inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/cardiac-monitoring-and-cardiac-rhythm-management-devices-market/request-for-sample

Market growth is primarily driven by the rising prevalence of cardiovascular disorders, growing adoption of remote patient monitoring system technologies, and increasing preference for minimally invasive cardiac procedures, along with continuous advancements in implantable and wearable cardiac devices.

Cardiac Monitoring and Cardiac Rhythm Management Devices Market Report Highlights

• Based on type, the cardiac monitoring devices segment dominated the market in 2024, driven by widespread adoption of ECG, Holter monitors, and implantable loop recorders for continuous monitoring and early detection of cardiac abnormalities.
• Based on procedure, the invasive segment dominated the market in 2024, driven by high adoption of implantable cardiac devices, rising arrhythmia and heart failure cases, and improved surgical outcomes.
• By application, the arrhythmia segment dominated the market in 2024, owing to increasing cases of atrial fibrillation and ventricular tachycardia, which require long-term monitoring and rhythm management solutions.
• By end user, the hospitals segment accounted for the largest share in 2024, supported by high patient inflow, advanced infrastructure for cardiac procedures, and availability of skilled healthcare professionals.
• North America dominated the market in 2024, driven by advanced healthcare infrastructure, high adoption of technologically advanced devices, and strong presence of key manufacturers.
• Asia Pacific is projected to grow at the fastest CAGR during the forecast period, fueled by rapid expansion of healthcare infrastructure, rising prevalence of cardiovascular diseases, and growing investments in digital health technologies in countries such as China and India.
• Key players in the global market include Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Biotronik SE & Co. KG, Nihon Kohden Corporation, Baxter International, Schiller AG, OSI Systems, Inc., AliveCor Inc., and MicroPort Scientific Corporation.

Polaris Market Research has segmented the market report based on type, procedure, application, end user, and region:

By Type Outlook (Revenue, USD Billion, 2020–2034)

• Cardiac Monitoring Device
  • ECG
  • Implantable Cardiac Monitors
  • Holter Monitors
  • Mobile Cardiac Telemetry
• Cardiac Rhythm Management Devices
  • Defibrillators
    • Implantable Cardioverter Defibrillators (ICD)
      • Single Chamber
      • Dual Chamber
    • External Defibrillator
      • Manual External Defibrillator
      • Automatic External Defibrillator
      • Wearable Cardioverter Defibrillator Pacemakers
  • Pacemakers
    • Conventional
    • Leadless

By Procedure Outlook (Revenue, USD Billion, 2020–2034)

• Invasive
• Non-invasive

By Application Outlook (Revenue, USD Billion, 2020–2034)

• Arrhythmias
• Myocardial Infarction
• Heart Failure
• Other Applications

By End User Outlook (Revenue, USD Billion, 2020–2034)

• Hospitals & Clinics
• Ambulatory Surgery Centers
• Other End Users

By Regional Outlook (Revenue, USD Billion, 2020–2034)

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America